Global Injectable Drug Delivery Market Analysis By Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), By Formulation Packaging (Ampoules, Vials, Cartridges, Bottles), By Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Cancer, Others), By Usage Pattern (Curative Care, Immunization, Others), By Site of Administration (Skin, Circulatory/Musculoskeletal System, Organs, Central Nervous System), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy Online Stores), By End User (Hospitals and Clinics, Home Care Settings, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: June 2024
- Report ID: 16898
- Number of Pages: 208
- Format:
-
keyboard_arrow_up
-
-
- Amgen Inc.
- Antares Pharma Inc.
- Becton, Dickinson and Company
- Consort Medical Plc (Bespak)
- Crossject
- Medtronic plc
- Mylan N.V.
- SHL Group
- West Pharmaceutical Services Inc.
- Ypsomed AG
- settingsSettings
Our Clients
- 16898
- June 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
